UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPK

International Journal of Molecular Sciences

Volumn 14, Issue 8, 2013, Pages 17029-17054

  Muthusamy, Visalini ^a,b   Piva, Terrence J ^a  

^a RMIT UNIVERSITY   (Australia)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Anisomycin; JNK; Melanocytes; Melanoma; NF B; p38; TNFa; UV

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; SALAZOSULFAPYRIDINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANISOMYCIN; ANTHRACENES; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; IMIDAZOLES; INTERLEUKIN-1ALPHA; MAP KINASE SIGNALING SYSTEM; MELANOCYTES; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIDINES; SULFASALAZINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883188948     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140817029     Document Type: Article

References (61)

1. Muthusamy, V.; Piva, T.J. Melanoma Cell Signaling: Looking Beyond RAS-RAF-MEK. In Skin Cancers-Risk Factors, Prevention and Therapy; Porta, C.L., Ed.; InTech: Rijeka, Croatia, 2011; pp. 87-108.
2. Sullivan, R.J.; Flaherty, K. MAP kinase signaling and inhibition in melanoma. Oncogene 2013, 32, 2373-2379.
3. Liu, F.; Singh, A.; Yang, Z.; Garcia, A.; Kong, Y.; Meyskens, F.L., Jr. MiTF links Erk1/2 kinase and p21CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol. Cancer 2010, 9, 214.
4. Enzler, T.; Sano, Y.; Choo, M.K.; Cottam, H.B.; Karin, M.; Tsao, H.; Park, J.M. Cell-selective inhibition of NFκB signaling improves therapeutic index in a melanoma chemotherapy model. Cancer Discov. 2011, 1, 496-507.
5. Keuling, A.M.; Andrew, S.E.; Tron, V.A. Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: Novel regulation of PUMA. Pigment Cell Melanoma Res. 2010, 23, 430-440.
6. Selimovic, D.; Hassan, M.; Haikel, Y.; Hengge, U.R. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cell Signal 2008, 20, 311-322.
7. Shieh, J.M.; Huang, T.F.; Hung, C.F.; Chou, K.H.; Tsai, Y.J.; Wu, W.B. Activation of c-jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells. Br. J. Pharmacol. 2010, 160, 1171-1184.
8. Alexaki, V.I.; Javelaud, D.; Mauviel, A. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis. Pigment Cell Melanoma Res. 2008, 21, 429-438.
9. Denkert, C.; Siegert, A.; Leclere, A.; Turzynski, A.; Hauptmann, S. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells. Clin. Exp. Metastasis 2002, 19, 79-85.
10. Estrada, Y.; Dong, J.; Ossowski, L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res. 2009, 22, 66-76.
11. Ivanov, V.N.; Fodstad, O.; Ronai, Z. Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFα and suppression of NFκB activities. Oncogene 2001, 20, 2243-2253.
12. Kannaiyan, R.; Manu, K.A.; Chen, L.; Li, F.; Rajendran, P.; Subramaniam, A.; Lam, P.; Kumar, A.P.; Sethi, G. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3K/Akt signaling pathways. Apoptosis 2011, 16, 1028-1041.
13. Ke, H.; Augustine, C.K.; Gandham, V.D.; Jin, J.Y.; Tyler, D.S.; Akiyama, S.K.; Hall, R.P.; Zhang, J.Y. Cyld inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways. J. Investig. Dermatol. 2013, 133, 221-229.
14. Hayden, M.S.; Ghosh, S. Signaling to NFκB. Genes Dev. 2004, 18, 2195-2224.
15. McNulty, S.E.; del Rosario, R.; Cen, D.; Meyskens, F.L., Jr.; Yang, S. Comparative expression of NFκB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Res. 2004, 17, 173-180.
16. McNulty, S.E.; Tohidian, N.B.; Meyskens, F.L., Jr. RelA, p50 and inhibitor of κBα are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. Pigment Cell Res. 2001, 14, 456-465.
17. Muthusamy, V.; Hodges, L.D.; Macrides, T.A.; Boyle, G.M.; Piva, T.J. Effect of novel marine nutraceuticals on IL-1α-mediated TNFα release from UVB-irradiated human melanocyte-derived cells. Oxid. Med. Cell Longev. 2011, 2011, 728645.
18. Ivanov, V.N.; Ronai, Z. Down-regulation of tumor necrosis factor α expression by activating transcription factor 2 increases UVC-induced apoptosis of late-stage melanoma cells. J. Biol. Chem. 1999, 274, 14079-14089.
19. Gray-Schopfer, V.C.; Karasarides, M.; Hayward, R.; Marais, R. Tumor necrosis factor-α blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res. 2007, 67, 122-129.
20. Tandle, A.; Hanna, E.; Lorang, D.; Hajitou, A.; Moya, C.A.; Pasqualini, R.; Arap, W.; Adem, A.; Starker, E.; Hewitt, S.; et al. Tumor vasculature-targeted delivery of tumor necrosis factor-α. Cancer 2009, 115, 128-139.
21. Ivanov, V.N.; Ronai, Z. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NFκB activity and Fas expression. Oncogene 2000, 19, 3003-3012.
22. Halliday, G.M.; Lyons, J.G. Inflammatory doses of UV may not be necessary for skin carcinogenesis. Photochem. Photobiol. 2008, 84, 272-283.
23. Muthusamy, V.; Piva, T.J. The UV response of the skin: A review of the MAPK, NFκB and TNFα signal transduction pathways. Arch. Dermatol. Res. 2010, 302, 5-17.
24. Johnson, G.L.; Nakamura, K. The c-Jun kinase/stress-activated pathway: Regulation, function and role in human disease. Biochim. Biophys. Acta 2007, 1773, 1341-1348.
25. Hayden, M.S.; Ghosh, S. Shared principles in NFκB signaling. Cell 2008, 132, 344-362.
26. Devalaraja, M.N.; Wang, D.Z.; Ballard, D.W.; Richmond, A. Elevated constitutive IκB kinase activity and IκBα phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GROα transcription. Cancer Res. 1999, 59, 1372-1377.
27. Clydesdale, G.J.; Dandie, G.W.; Muller, H.K. Ultraviolet light induced injury: Immunological and inflammatory effects. Immunol. Cell Biol. 2001, 79, 547-568.
28. Duthie, M.S.; Kimber, I.; Norval, M. The effects of ultraviolet radiation on the human immune system. Br. J. Dermatol. 1999, 140, 995-1009.
29. Ullrich, S.E.; Byrne, S.N. The immunologic revolution: Photoimmunology. J. Investig. Dermatol. 2012, 132, 896-905.
30. Bashir, M.M.; Sharma, M.R.; Werth, V.P. UVB and proinflammatory cytokines synergistically activate TNFα production in keratinocytes through enhanced gene transcription. J. Investig. Dermatol. 2009, 129, 994-1001.
31. Hazzalin, C.A.; Le Panse, R.; Cano, E.; Mahadevan, L.C. Anisomycin selectively desensitizes signaling components involved in stress kinase activation and fos and jun induction. Mol. Cell Biol. 1998, 18, 1844-1854.
32. Johansson, P.; Pavey, S.; Hayward, N. Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res. 2007, 20, 216-221.
33. Castellano, M.; Pollock, P.M.; Walters, M.K.; Sparrow, L.E.; Down, L.M.; Gabrielli, B.G.; Parsons, P.G.; Hayward, N.K. CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res. 1997, 57, 4868-4875.
34. Pope, J.H.; Morrison, L.; Moss, D.J.; Parsons, P.G.; Regius Mary Sister. Human malignant melanoma cell lines. Pathology 1979, 11, 191-195.
35. Kadekaro, A.L.; Kavanagh, R.J.; Wakamatsu, K.; Ito, S.; Pipitone, M.A.; Abdel-Malek, Z.A. Cutaneous photobiology. The melanocyte vs. the sun: Who will win the final round? Pigment Cell Res. 2003, 16, 434-447.
36. Kaidbey, K.H.; Agin, P.P.; Sayre, R.M.; Kligman, A.M. Photoprotection by melanin-A comparison of black and caucasian skin. J. Am. Acad. Dermatol. 1979, 1, 249-260.
37. Kobayashi, N.; Nakagawa, A.; Muramatsu, T.; Yamashina, Y.; Shirai, T.; Hashimoto, M.W.; Ishigaki, Y.; Ohnishi, T.; Mori, T. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J. Investig. Dermatol. 1998, 110, 806-810.
38. Yohn, J.J.; Norris, D.A.; Yrastorza, D.G.; Buno, I.J.; Leff, J.A.; Hake, S.S.; Repine, J.E. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J. Investig. Dermatol. 1991, 97, 405-409.
39. Koch-Paiz, C.A.; Amundson, S.A.; Bittner, M.L.; Meltzer, P.S.; Fornace, A.J., Jr. Functional genomics of UV radiation responses in human cells. Mutat. Res. 2004, 549, 65-78.
40. Besaratinia, A.; Kim, S.I.; Pfeifer, G.P. Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J. 2008, 22, 2379-2392.
41. Schieke, S.M.; Ruwiedel, K.; Gers-Barlag, H.; Grether-Beck, S.; Krutmann, J. Molecular crosstalk of the ultraviolet A and ultraviolet B signaling responses at the level of mitogen-activated protein kinases. J. Investig. Dermatol. 2005, 124, 857-859.
42. Sabapathy, K.; Wagner, E.F. Jnk2: A negative regulator of cellular proliferation. Cell Cycle 2004, 3, 1520-1523.
43. Chen, N.; Nomura, M.; She, Q.B.; Ma, W.Y.; Bode, A.M.; Wang, L.; Flavell, R.A.; Dong, Z. Suppression of skin tumorigenesis in c-Jun NH2-terminal kinase-2-deficient mice. Cancer Res. 2001, 61, 3908-3912.
44. Tao, J.; Gao, Y.; Li, M.O.; He, W.; Chen, L.; Harvev, B.; Davis, R.J.; Flavell, R.A.; Yin, Z. JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response. Eur. J. Immunol. 2007, 37, 818-829.
45. Alsina, J.; Gorsk, D.H.; Germino, F.J.; Shih, W.; Lu, S.E.; Zhang, Z.G.; Yang, J.M.; Hait, W.N.; Goydos, J.S. Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma. Clin. Cancer Res. 2003, 9, 6419-6425.
46. Hoshino, R.; Chatani, Y.; Yamori, T.; Tsuruo, T.; Oka, H.; Yoshida, O.; Shimada, Y.; Ari-i, S.; Wada, H.; Fujimoto, J.; et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999, 18, 813-822.
47. Collisson, E.A.; de, A.; Suzuki, H.; Gambhir, S.S.; Kolodney, M.S. Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade. Cancer Res. 2003, 63, 5669-5673.
48. Pavey, S.; Johansson, P.; Packer, L.; Taylor, J.; Stark, M.; Pollock, P.M.; Walker, G.J.; Boyle, G.M.; Harper, U.; Cozzi, S.J.; et al. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 2004, 23, 4060-4067.
49. Lopez-Bergami, P.; Huang, C.; Goydos, J.S.; Yip, D.; Bar-Eli, M.; Herlyn, M.; Smalley, K.S.; Mahale, A.; Eroshkin, A.; Aaronson, S.; et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007, 11, 447-460.
50. Shang, J.; Schwarz, C.; Sanchez Ruderisch, H.; Hertting, T.; Orfanos, C.E.; Tebbe, B. Effects of UVA and L-ascorbic acid on nuclear factor-κB in melanocytes and in HaCaT keratinocytes. Skin Pharmacol. Appl. Skin Physiol. 2002, 15, 353-359.
51. Djavaheri-Mergny, M.; Gras, M.P.; Mergny, J.L.; Dubertret, L. UVA-induced decrease in nuclear factor-κB activity in human keratinocytes. Biochem. J. 1999, 338, 607-613.
52. Kondo, S.; Jimbow, K. Dose-dependent induction of IL-12 but not IL-10 from human keratinocytes after exposure to ultraviolet light a. J. Cell Physiol. 1998, 177, 493-498.
53. Basile, J.R.; Eichten, A.; Zacny, V.; Munger, K. NF-κB-mediated induction of p21(cip1/waf1) by tumor necrosis factor α induces growth arrest and cytoprotection in normal human keratinocytes. Mol. Cancer Res. 2003, 1, 262-270.
54. Szoltysek, K.; Pietranek, K.; Kalinowska-Herok, M.; Pietrowska, M.; Kimmel, M.; Widlak, P. TNFα-induced activation of NFκB protects against UV-induced apoptosis specifically in p53-proficient cells. Acta Biochim. Pol. 2008, 55, 741-748.
55. Ravi, D.; Muniyappa, H.; Das, K.C. Caffeine inhibits UV-mediated NFκB activation in A2058 melanoma cells: An ATM-PKCδ-p38 MAPK-dependent mechanism. Mol. Cell Biochem. 2008, 308, 193-200.
56. Jinlian, L.; Yingbin, Z.; Chunbo, W. p38 MAPK in regulating cellular responses to ultraviolet radiation. J. Biomed. Sci. 2007, 14, 303-312.
57. Weston, C.R.; Davis, R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 2007, 19, 142-149.
58. Krohne, T.U.; Hunt, S.; Holz, F.G. Effect of 308 nm excimer laser irradiation on retinal pigment epithelium cell viability in vitro. Br. J. Ophthalmol. 2009, 93, 91-95.
59. Mikita, N.; Kanazawa, N.; Yoshimasu, T.; Ikeda, T.; Li, H.J.; Yamamoto, Y.; Furukawa, F. The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL/lpr mice. Clin. Dev. Immunol. 2009, 2009, 673952.
60. Kuchel, J.M.; Barnetson, R.S.; Halliday, G.M. Ultraviolet A augments solar-simulated ultraviolet radiation-induced local suppression of recall responses in humans. J. Investig. Dermatol. 2002, 118, 1032-1037.
61. Huynh, T.T.; Chan, K.S.; Piva, T.J. Effect of ultraviolet radiation on the expression of pp38MAPK and furin in human keratinocyte-derived cell lines. Photodermatol. Photoimmunol. Photomed. 2009, 25, 20-29.